Congenital heart diseaseCohort study

Haemodynamic Contributors to Pulmonary Hypertension Across the Spectrum of Adult Congenital Heart Disease

Eur J Heart FailPublished

  • Retrospective cohort study
  • single-centre

Authors' conclusion

Elevation of mPAP ≥25 mmHg in ACHD with a biventricular circulation is prognostically important regardless of disease phenotype, but milder PH of 21-25 mmHg is not associated with adverse outcome unless associated with Fontan circulation. Elevation in PVP >15 mmHg and PVR ≥3 Wood units were each individually associated with mortality with combined abnormalities associated with greatest risk.

Study context

Population
Adult congenital heart disease (ACHD) patients undergoing cardiac catheterization at Mayo Clinic, 1999–2022
Participants
1,005 patients
Exposure
Haemodynamic abnormalities and death/heart transplantation
Outcome
Combined endpoint of death/heart transplantation

Main finding

As reported in the abstract

Death/transplant (biventricular circulation)
Hazard ratio (95% CI)P value
PVR ≥3 Wood unitsnot at lower recommended cutpoints
3.00(2.17–4.15)
P < 0.0001
mPAP ≥25 mmHgnot at lower recommended cutpoints
3.15(2.17–4.58)
P < 0.0001
Combined PVP and PVR abnormalitiesworst outcome
5.20(3.55–7.63)
P < 0.0001
Either PVP or PVR abnormalityintermediate risk
2.11(1.46–3.04)
P < 0.0001

Observational data: associations, not effects.

Further findings

Prevalence of mean pulmonary artery pressure (mPAP) ≥25 mmHg

mPAP ≥25 mmHg
37%

Fontan (univentricular) circulation

Only with Fontan circulation was a lower mPAP threshold (20 mmHg) associated with adverse outcomes

Original publication

Haemodynamic Contributors to Pulmonary Hypertension Across the Spectrum of Adult Congenital Heart Disease. Eur J Heart Fail. Published 2 July 2024. doi:10.1002/ejhf.3366

Summarised from the published abstract; every number is checked against it